Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $30

Benzinga · 3d ago
Oppenheimer analyst Jeff Jones maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $32 to $30.